Examining self-recognition and self/other distinction in young people with psychological vulnerability
Official title: Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability (ALTER EGO)
Run by University Hospital, Brest · NCT04945278 · Data updated 2026-11-12
This study is testing how young people with psychological challenges see themselves and others using a special mirror to see if it’s different from those without these challenges.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 25 Years |
| Sex | All |
| Enrollment | 34 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 1 site (Bohars) |
| Status | Recruiting |
| Started | May 31, 2022 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT04945278 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 15 to 25 who meet the Ultra High Risk criteria for psychosis.
✕Probably not a fit
Patients with a history of epilepsy, migraine, or significant visual impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to investigate differences in self-recognition and self/other distinction between individuals with psychological vulnerability and healthy controls. Participants will engage with a double mirror device that morphs their image into that of another person, allowing researchers to assess their perception of self and others. The study focuses on young individuals aged 15 to 25, utilizing a specific testing paradigm to explore potential links between these cognitive abilities and psychological symptoms. By comparing responses from both groups, the research seeks to enhance understanding of psychological vulnerabilities in youth.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and therapeutic strategies for young individuals at risk of psychosis.
How similar studies have gone: While the specific approach using the double mirror paradigm is novel, similar studies have explored self-recognition in psychological contexts with varying degrees of success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria for patients: * Aged from 15 to 25 years * Subject meeting the Ultra High Risk criteria at CAARMS and / or SPI-A * Signature of the consent (participants and parents for minors) * Subject affiliated to the social security scheme or benefiting from such a scheme Inclusion criteria for healthy volunteers: * Aged from 15 to 25 years * Subject not familiar to the patient to whom it is matched * Signature of the consent (participants and parents for minors) * Subject affiliated to the social security scheme or benefiting from such a scheme Exclusion Criteria for both patients and healthy volunteers: * History of epilepsy and / or migraine (due to the epileptogenic potential of light stimuli) * Refusal of participation of the minor even if the legal representatives want the subject to participate in the study * Claustrophobia * Wearing glasses * Abnormal right and left visual acuity without contact lenses * Distinctive signs on the face which cannot be temporarily removed * Subject under legal protection (curators / guardianship) or deprived of liberty
Where it's running
-
CHRU BREST Hôpital de Bohars
Bohars, France Recruiting
Study contacts
- Principal investigator: Nathalie LAVENNE — Chru Brest
- Study coordinator: Nathalie LAVENNE
- Email: nathalie.lavenne-collot@chu-brest.fr
- Phone: 02 98 01 50 46
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Speech-based test to estimate relapse risk in psychosis
This project will try using weekly smartphone speech recordings and short self-reports to see if an automated system can predict relapse risk in people with psychosis.
-
Changing Lives and Changing Outcomes-9 group program at Worcester Recovery Center and Hospital
This program will try a nine-session cognitive-behavioral group to help adults with serious mental illness who have current or past legal involvement increase mental health awareness and lower chances of future legal problems.
-
Deprescribing antipsychotics using multiple real patient cases
This project will see if reducing or stopping long-term antipsychotics works for adults with stable psychotic disorders by following real-world cases.
-
Cognitive Strategies in Early Psychosis 2 – how brain games and pills test decision making
This study tests whether a single dose of modafinil or d-serine, compared with placebo, changes decision making in people aged 18–35 who have recently begun experiencing psychosis.
-
Long-term supervised exercise program to improve fitness and quality of life for inpatients with psychosis
This program tries a long-term supervised exercise routine, including Pilates, to see if it improves physical function and quality of life for adults hospitalized with psychotic disorders.
-
iTEST: a blended mobile program to improve introspective accuracy (accurate self-judgment of abilities)
This trial tests whether iTEST — daily mobile cognitive training plus coaching that focuses on accurate self-judgment — helps adults with schizophrenia-spectrum or other psychotic disorders improve community functioning.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.